v3 Template
S

Seres Therapeutics

Biotechnology/Healthcare CAMBRIDGE, Mass. ~440 employees
Founded
--
Employees (Est.)
~440
22 leaders known
Total Funding
$278.6M
Funding Rounds
3
Last Funding
2026-07-01

About Seres Therapeutics

Seres Therapeutics is dedicated to transforming the lives of patients worldwide by developing revolutionary live biotherapeutics. Their mission focuses on creating new treatments for medically vulnerable populations to prevent bacterial bloodstream and antimicrobial resistant (AMR) infections, as well as to treat GI-related immune diseases.

Products & Services

VOWST™:A biotherapeutic product involved in an asset sale agreement with Nestlé Health Science.
Live Biotherapeutics:Innovative treatments targeting bacterial bloodstream infections, antimicrobial resistant infections, and GI-related immune diseases.
VOWST

Specialties

Live Biotherapeutics Microbiome Health Prevention of Bacterial Infections Treatment of GI-related Immune Diseases Antimicrobial Resistance (AMR)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Other
T: -
FT: Other 		A: 25000000
MR: -
FA: $25 million
FAN: 25000000 		D: 2026-07-01
FD: 2026-07-01 		1 investors
2 RT: Grant
T: -
FT: Grant 		A: 3600000
MR: -
FA: up to $3.6 million
FAN: 3600000 		D: 2025-10-29
FD: 2025-10-29 		1 investors
3 RT: Debt
T: -
FT: Debt 		A: 250000000
MR: -
FA: $250 million
FAN: 250000000 		D: 2023-04-27
FD: 2023-04-27 		1 investors
Other Latest
2026-07-01
$25.0M
1 investor (Pro only)
Grant 2025-10-29
$3.6M
Debt 2023-04-27
$250.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Richard Kender

Executive Chair and Interim Chief Executive Officer

M

Matthew Henn

President and Chief Scientific Officer

K

Kelly Brady

EVP, Chief Operating Officer

T

Thomas J. DesRosier

EVP, Chief Legal Officer

C

Chris McChalicher

EVP, Chief Technology Officer

M

Marella Thorell

EVP, Chief Financial Officer

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Seres Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~440 employees (est.)
Locations
CAMBRIDGE, Mass.
Cambridge, Mass.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro